We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · September 09, 2021

ESC 2021: PRONOUNCE Fails to Differentiate Cardiovascular Risk of Degarelix Versus Leuprolide for Prostate Cancer Patients With Cardiovascular Disease

Early enrollment termination and other study limitations hamper interpretation of findings

PracticeUpdate Editorial Team